相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment
Lumei Kang et al.
JOURNAL OF NEUROLOGY (2021)
Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity
Vanessa Pereira et al.
MOLECULAR NEUROBIOLOGY (2021)
Mechanistic insights into p53-regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells
Christian Marx et al.
MOLECULAR ONCOLOGY (2021)
Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice
Hana Starobova et al.
JOURNAL OF PAIN (2020)
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy
Stephen N. Housley et al.
CANCER RESEARCH (2020)
Integrative Modeling of a Sin3/HDAC Complex Sub-structure
Charles A. S. Banks et al.
CELL REPORTS (2020)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The pseudo-caspase FLIP(L) regulates cell fate following p53 activation
Andrea Lees et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Oxaliplatin-induced haematological toxicity and splenomegaly in mice
Justin G. Lees et al.
PLOS ONE (2020)
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Alex Molassiotis et al.
BMC CANCER (2019)
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells
Nicole Kiweler et al.
ARCHIVES OF TOXICOLOGY (2018)
Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer
Ping He et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Deregulated expression of HDAC3 in colorectal cancer and its clinical significance
Masoumeh Nemati et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model
Robert J. Danaher et al.
MOLECULAR PAIN (2018)
Entinostat: a promising treatment option for patients with advanced breast cancer
Roisin M. Connolly et al.
FUTURE ONCOLOGY (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
Lin-Lin Cao et al.
ONCOTARGET (2017)
Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
Shota Yamamoto et al.
SCIENTIFIC REPORTS (2017)
SARTools: A DESeq2-and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data
Hugo Varet et al.
PLOS ONE (2016)
Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry
Antoinetta J. M. Beijers et al.
ACTA ONCOLOGICA (2015)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges
Aristeidis G. Vaiopoulos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Different Effects of Epigenetic Modifiers on the Cytotoxicity Induced by 5-Fluorouracil, Irinotecan or Oxaliplatin in Colon Cancer Cells
Mika Ikehata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
J. Sonnemann et al.
BRITISH JOURNAL OF CANCER (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception
Vanessa Pereira et al.
PAIN (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade
Gabriela Trevisan et al.
CANCER RESEARCH (2013)
The contribution of satellite glial cells to chemotherapy-induced neuropathic pain
R. A. Warwick et al.
EUROPEAN JOURNAL OF PAIN (2013)
Toxicological and metabolic considerations for histone deacetylase inhibitors
Joanna Fraczek et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain
Franziska Denk et al.
PAIN (2013)
A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats
Jeremy Ferrier et al.
PLOS ONE (2013)
CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data
Jason E. Shoemaker et al.
BMC GENOMICS (2012)
P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in Human colon Cancer cells
Yao Zhan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice
Meng Zhao et al.
MOLECULAR PAIN (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
CHARACTERIZATION OF OXALIPLATIN-INDUCED CHRONIC PAINFUL PERIPHERAL NEUROPATHY IN THE RAT AND COMPARISON WITH THE NEUROPATHY INDUCED BY PACLITAXEL
W. H. Xiao et al.
NEUROSCIENCE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
Juliette Descoeur et al.
EMBO MOLECULAR MEDICINE (2011)
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy
Huaien Zheng et al.
EXPERIMENTAL NEUROLOGY (2011)
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation
Romina Nassini et al.
PAIN (2011)
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models
Tomke Ute Bracker et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice
Punam Gauchan et al.
NEUROSCIENCE LETTERS (2009)
A review on oxaliplatin-induced peripheral nerve damage
Andreas A. Argyriou et al.
CANCER TREATMENT REVIEWS (2008)
Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
Sachiko Yokoo et al.
DRUG METABOLISM AND DISPOSITION (2008)
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
Ivana Gojo et al.
BLOOD (2007)
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex
S Rampalli et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss
SMF Jamieson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
D Arango et al.
BRITISH JOURNAL OF CANCER (2004)
Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis
P Zhu et al.
CELL CYCLE (2004)
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels
F Grolleau et al.
JOURNAL OF NEUROPHYSIOLOGY (2001)
Immunohemolytic anemia following oxaliplatin administration
C Garufi et al.
ANNALS OF ONCOLOGY (2000)
分享论文
